Tuberculosis treatment in a refugee and migrant population: 20 years of experience on the Thai-Burmese border

SETTING: Although tuberculosis (TB) is a curable disease, it remains a major global health problem and an important cause of morbidity and mortality among vulnerable populations, including refugees and migrants.OBJECTIVE: To describe results and experiences over 20 years at a TB programme in refugee...

Full description

Saved in:
Bibliographic Details
Published in:The international journal of tuberculosis and lung disease Vol. 14; no. 12; pp. 1589 - 1595
Main Authors: MINETTI, A, CAMELIQUE, O, HSA THAW, K, THI, S, SWADDIWUDHIPONG, W, HEWISON, C, PINOGES, L, BONNET, M, GUERIN, P. J
Format: Journal Article
Language:English
Published: Paris, France IUATLD 01-12-2010
International Union against Tuberculosis and Lung Disease
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:SETTING: Although tuberculosis (TB) is a curable disease, it remains a major global health problem and an important cause of morbidity and mortality among vulnerable populations, including refugees and migrants.OBJECTIVE: To describe results and experiences over 20 years at a TB programme in refugee camps on the Thai-Burmese border in Tak Province, Thailand, and to identify risk factors associated with adverse outcomes (e.g., default, failure, death).DESIGN: Retrospective review of routine records of 2425 patients admitted for TB treatment in the Mae La TB programme between May 1987 and December 2005.RESULTS: TB cases notified among refugees decreased over 20 years. Among patients treated with a first-, second- or third-line regimen, 77.5% had a successful outcome, 13.5% defaulted, 7.6% died and 1.3% failed treatment. Multivariate analysis for new cases showed higher likelihood of adverse outcomes for patients who were Burmese migrants or Thai villagers, male, aged >15 years or with smear-negative pulmonary TB.CONCLUSION: These findings suggest that treatment outcomes depend on the programme's capacity to respond to specific patients' constraints. High-risk groups, such as migrant populations, need a patient-centred approach, and specific, innovative strategies have to be developed based on the needs of the most vulnerable and marginalised populations.
Bibliography:1027-3719(20101201)14:12L.1589;1-
(R) Medicine - General
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:1027-3719
1815-7920